P3 Health PartnersPIII
13F holders, Q4 2025 (December 31)12holders −2
0new positions
2sold out
$3.49avg. 13F price*
At the end of Q4 2025, 12 institutions reported holding P3 Health Partners Inc. (PIII) in their 13F filings, down 2 from Q3 2025. 0 opened new positions and 2 sold out. The largest holders were Alyeska Investment Group, L.P. ($480K), Vanguard Group Inc. ($168K) and Geode Capital Management, LLC ($75K).
- Company
- P3 Health Partners Inc.
- CUSIP
- 744413204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $627 |
All 13F filers, Q3 2025 → Q4 2025: 2,469 shares bought and 59,749 shares sold, net −57,280 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Alyeska Investment Group, L.P. | 0.00% | Reduce -24.1% | 137,406 | $480K |
| Vanguard Group Inc. | 0.00% | Reduce -1.2% | 48,117 | $168K |
| Geode Capital Management, LLC | 0.00% | Add +5.1% | 21,408 | $75K |
| Corient Private Wealth LP | 0.00% | Reduce -41.1% | 20,837 | $73K |
| BlackRock, Inc. | 0.00% | Add +1.1% | 10,660 | $37K |
| Blair William & Co. | 0.00% | Reduce -0.1% | 3,092 | $11K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 1,373 | $5K |
| UBS Group AG | 0.00% | Add +609.7% | 951 | $3K |
| Bank of America Corp. | 0.00% | Add +50000.0% | 501 | $2K |
| BNP Paribas Financial Markets | 0.00% | Reduce -55.0% | 36 | $126 |
| JPMorgan Chase & Co. | 0.00% | Reduce -98.1% | 19 | $67 |
| Royal Bank of Canada | 0.00% | No change | 2 | $0 |
"% of holder's portfolio" is PIII's weight in each manager's 13F, not the share of P3 Health Partners Inc. the manager owns.